February 2023 - Clinical Informatics - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Clinical Informatics.
1914: "Mayo Clinic" becomes Official Name #ThrowbackThursday - Insights
Given the stature of Mayo Clinic, it can be surprising to learn that this name was not developed by a high-powered consulting firm. Audience analytics and focus group metrics played no part in creating it. For that matter, even the people...
Prostate Health Index (phi) [Test in Focus] - Insights
Useful For Assessing the patient’s probability of having detectable prostate cancer when totalprostate specific antigen (PSA) concentrations are between
Axonal autoimmune neuropathies - Insights
Find out about our panel-based approach to axonal autoimmune neuropathies, which we recommend because of the overlap in clinical symptoms.
August 2021 - Clinical Microbiology and Infectious Disease Pathology - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Clinical Microbiology.
April 2023 - Gynecological Pathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Gynecological Pathology.
October 2023 - Coagulation - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Coagulation.
June 2023 - Neuropathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Neuropathology.
Comprehensive urine drug profiles - Insights
Mayo Clinic Laboratories’ comprehensive controlled substance monitoring profiles use multiple methodologies to detect the lowest levels of substances.
Learn more about how Mayo Clinic Laboratories’ targeted, high-resolution screening panel for stimulant use identifies and confirms the presence of 10 stimulants and phencyclidine (PCP) with a single test.